Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Infants/children with cow's milk allergy will take part in 2 double-blinded placebo-controlled food challenges (DBPCFC) of 2 extensively hydrolyzed formulas in random order. If both food challenges are passed, subjects will be asked to consume the Test formula in an at-home open challenge for 7 days.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Test then Control | Active Comparator | Subjects will perform a DBPCFC with the Test formula followed by the Control formula |
|
| Control then Test | Active Comparator | Subjects will perform a DBPCFC with the Control formula followed by the Test formula |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Test extensively hydrolyzed formula | Other | extensively hydrolyzed formula made with a new enzyme |
|
| Measure | Description | Time Frame |
|---|---|---|
| allergic reaction | number of children who react during a DBPCFC to either formula | 2 hours post-DBPCFC |
| Measure | Description | Time Frame |
|---|---|---|
| stool characteristics | stool descriptors as collected on daily diaries | 1 week |
| formula intake | amount of formula ingested as collected on daily diaries |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Anna Nowak-Wegrzyn, MD | Mt. Sinai | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Atria Clinical Research | Little Rock | Arkansas | United States | |||
| Allergy and Asthma Associates of Southern California |
Not provided
Not provided
Not provided
Not provided
Not provided
| Control extensively hydrolyzed formula | Other | commercially available extensively hydrolyzed formula |
|
| 1 week |
| adverse events | any adverse event reported by caregivers | 1 week |
| Mission Viejo |
| California |
| United States |
| All Children's Hospital | St. Petersburg | Florida | United States |
| AeroAllergy | Savannah | Georgia | United States |
| Mt. Sinai | New York | New York | United States |
| ENT & Allergy Associates | Newburgh | New York | United States |
| Allergy and Sinus Relief Center/Great Lakes Medical research | Chardon | Ohio | United States |
| Allergy Asthma Research Institute | Waco | Texas | United States |
| ID | Term |
|---|---|
| D016269 | Milk Hypersensitivity |
| ID | Term |
|---|---|
| D005512 | Food Hypersensitivity |
| D006969 | Hypersensitivity, Immediate |
| D006967 | Hypersensitivity |
| D007154 | Immune System Diseases |
Not provided
Not provided